For the purposes of this discussion, Dr. Soumekh described gastrointestinal (GI) and esophageal issues that may be more likely to affect people with myositis, focusing on oropharyngeal disorders, ...

Will add UNLOXCYTtm (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco ...

🌟 I'm thrilled to announce the publication of our challenging and rare case report: "Isolated Orbital Eosinophilic Myositis With Peripheral Eosinophilia: A Challenging Diagnosis." This unique ...

Sorry, no items found. Please try again with different keywords.

Find Additional Treatment Centers at: ...